For patients that have completed treatment for colorectal cancer and have entered surveillance, NCCN, ESMO, and JSCCR recommend follow-up with physical examination, monitoring of CEA levels, CT chest-abdomen-pelvis, and colonoscopy. Here, CEACAM5 is linked to colorectal cancer.